Description
Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 3/12: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis
A61P 3/12
Sub-Class
Stats
- 25 US PATENTS IN FORCE
- 8 US APPLICATIONS PENDING
- 4 Total Patent Owners
- 224 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 11992501 | Compositions for and methods of treating acid-base disorders | Sep 24, 21 | May 28, 24 | RENOSIS, INC. |
| 11858959 | Glycyrrhetinic acid derivatives for use in treating hyperkalemia | Feb 06, 20 | Jan 02, 24 | Ardelyx, Inc. |
| 11752106 | Pharmaceutical composition and administrations thereof | Sep 15, 21 | Sep 12, 23 | Vertex Pharmaceuticals Incorporated |
| 11738041 | Proton-binding polymers for oral administration | Apr 19, 22 | Aug 29, 23 | RENOSIS, INC. |
| 11446306 | Bicyclic bromodomain inhibitors | Jul 28, 20 | Sep 20, 22 | Zenith Epigenetics Ltd. |
| 11406661 | HCl-binding compositions for and methods of treating acid-base disorders | May 05, 17 | Aug 09, 22 | TRICIDA, INC. |
| 11376234 | Ammonia metabolism promoter | May 31, 18 | Jul 05, 22 | Kao Corporation |
| 11357747 | Amino acid compositions for the amelioration of symptoms of hangover | Aug 07, 20 | Jun 14, 22 | ENTRINSIC, INC.; University of Florida Research Foundation Incorporated; |
| 11345899 | Variant forms of urate oxidase and use thereof | Jun 24, 20 | May 31, 22 | HORIZON THERAPEUTICS USA, INC. |
| 11242337 | Compounds useful for treating gastrointestinal tract disorders | Jan 09, 18 | Feb 08, 22 | Ardelyx, Inc. |
| 11197887 | Proton-binding polymers for oral administration | Aug 16, 19 | Dec 14, 21 | TRICIDA, INC. |
| 11147884 | Inhibitors of NHE-mediated antiport | Jan 09, 18 | Oct 19, 21 | Ardelyx, Inc. |
| 11066399 | Ferroportin inhibitors | Dec 03, 20 | Jul 20, 21 | VIFOR (INTERNATIONAL) AG |
| 11001579 | Ferroportin inhibitors | Jun 12, 19 | May 11, 21 | VIFOR (INTERNATIONAL) AG |
| 10954211 | Chemical compounds | May 10, 19 | Mar 23, 21 | AstraZeneca AB |
| 10888599 | Compositions and methods to improve exercise performance and recovery | Jun 13, 16 | Jan 12, 21 | Beachbody, LLC |
| 10822319 | Crystal of DPP-IV long-acting inhibitor and salt | Aug 11, 17 | Nov 03, 20 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD.; CENTAURUS BIOPHARMA CO., LTD.; |
| 10772892 | Bicyclic bromodomain inhibitors | Jun 13, 19 | Sep 15, 20 | Zenith Epigenetics Ltd. |
| 10738041 | Ferroportin inhibitors | Oct 21, 16 | Aug 11, 20 | VIFOR (INTERNATIONAL) AG |
| 10364239 | Ferroportin inhibitors | Oct 21, 16 | Jul 30, 19 | VIFOR (INTERNATIONAL) AG |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2022/0347,141 | METHODS OF TREATING PHOSPHATE CONCENTRATION DISORDERS WITH L-BAIBA | Sep 17, 20 | Nov 03, 22 | Not available |
| 2022/0306,610 | COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS | Dec 21, 21 | Sep 29, 22 | Ardelyx, Inc. |
| 2022/0233,580 | SODIUM EXCRETION PARTICLES | May 26, 20 | Jul 28, 22 | Not available |
| 2022/0071,938 | TREATMENT OF HYPERAMMONEMIA IN PATIENTS WITH RENAL INSUFFICIENCY | Oct 20, 21 | Mar 10, 22 | Not available |
| 2022/0000,766 | PARENTERAL NUTRITION CONTAINING TRACE ELEMENTS | Jul 01, 21 | Jan 06, 22 | American Regent, Inc. |
| 2021/0106,611 | METHOD OF TREATING ACID-BASE DISORDERS | Dec 03, 20 | Apr 15, 21 | Not available |
| 2021/0077,437 | METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE | Dec 01, 20 | Mar 18, 21 | Not available |
| 2019/0209,607 | COMPOSITIONS FOR TREATING ACID-BASE DISORDERS | May 05, 17 | Jul 11, 19 | Not available |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 29 Months (last 2 years Issuances)
- 29 Months (last 5 years Issuances)